Why are Medicare and Medicaid shown separately instead of combined?

They come from two different CMS data sources with no shared claim identifier, so they can't be reconciled into one number without double-counting or guessing. Every table and chart on this page keeps them fully separate.

Why is there no private/commercial revenue figure?

Private and commercial payer data comes from Transparency in Coverage files, which only publish negotiated rates — not claims or utilization volume. Without a volume figure, no revenue number can be computed for any provider from that data.

What does "Rank" mean in the Competitive Analysis & Benchmarks tables?

For a given CPT/HCPCS code, it's this provider's position by claims volume among all providers billing that same code at that geography level (State, National, or Florida for Medicaid) — rank 1 means the highest claims volume for that code.

Why is the Medicaid comparison limited to Florida only?

Medicaid is administered per-state with no single national fee schedule, so a state or national comparison the way Medicare has one isn't available. Florida (this provider's own state) is the only grouping that's conceptually meaningful.

Why are the numbers rounded to the nearest 10?

To avoid implying more precision than the underlying data supports at a single-provider level. Ratios are kept precise since they're a relative comparison, not a volume or dollar figure.

How current is this data?

The Medicare and Medicaid tables are both single current snapshots, not refreshed on a recurring schedule yet.

Ahmed Alkaliby (NPI 1831868512)

Field	Value
Entity Type	Individual
Organization	Ahmed Alkaliby
Address	8786 Perimeter Park Blvd
City	Jacksonville
State	FL
ZIP	32216
Taxonomy	Ophthalmology Physician
NPI Enumerated	September 7, 2021

Payer Source	Total Paid
Medicare	$2.6M
Medicaid	$0

Key Findings

This provider’s Medicare footprint is the sole payer presence on file: Total Medicare revenue is $2.6M and there is no Medicaid billing on file, so operational exposure is effectively single-payer Medicare. The NPI was enumerated 2021-09-07 (~5 years ago), indicating about a five-year tenure in the Medicare program to date.

Revenue is highly concentrated in a small set of retinal therapeutics: the precomputed top-3 Medicare codes account for 89.2% of the provider’s Medicare revenue, with J0178 alone contributing $2M (78.6% of Medicare revenue). The next two contributors are 67028 at $160.3K (6.2%) and J2778 at $116.6K (4.5%), highlighting a narrow revenue base tied to intravitreal drug administration.

The code mix points to a retina-focused, injection-oriented practice model: J0178 (aflibercept) and J2778 (ranibizumab) are anti-VEGF biologics and 67028 is the intravitreal injection procedure, while 92134 (retinal imaging/OCT) at $62.5K supports on‑site diagnostic imaging. These patterns indicate the provider’s operations are centered on outpatient intravitreal injections coupled with diagnostic retinal imaging rather than broad multispecialty ophthalmology services.

Competitive standing for the dominant drug is strong: J0178 ranks #188 of 3204 nationally (94th percentile; notably above typical national volume for this code), signaling materially higher-than-typical national injection volume for aflibercept. Imaging capacity also appears strong: 92134 ranks #901 of 26868 (97th percentile; notably above typical national volume), which supports the view of a high-volume retina/imaging workflow.

Other biologics and injection-related codes show mixed participation versus peers. J2778 (ranibizumab) reports 648 claims and $116.6K (rank #605 of 1208, 50th percentile; typical, unremarkable volume), while J2777 (faricimab) shows 3.2K claims but a lower $92.2K revenue and ranks #1797 of 2039 (11th percentile; typical, unremarkable volume), suggesting differing utilization or reimbursement profiles across specific anti‑VEGF agents.

Non-injection ambulatory care and E/M services are present but secondary to drug and procedure revenue: 99214 accounts for $27.9K from 340 claims (rank #86256 of 479517, 82th percentile; typical, unremarkable volume) and 99213 accounts for $12.1K from 201 claims (rank #97778 of 457151, 78th percentile; typical, unremarkable volume). This pattern indicates routine office visit volume consistent with an outpatient retina practice where most revenue is driven by therapeutics and imaging.

There is evidence of supplemental biologic use beyond the headline anti-VEGF agent: J3590 (unclassified biologics) records 460 claims for $20.2K and ranks #74 of 631 (88th percentile; typical, unremarkable volume). While dollar impact is modest relative to J0178, the percentile suggests above-typical use of miscellaneous biologics among a small national peer set.

The heavy reliance on a single high-revenue drug line creates concentration risk from a business perspective: with J0178 accounting for $2M and the precomputed top-3 share at 89.2%, changes in aflibercept demand, clinical guidelines, or reimbursement for that code could materially affect overall Medicare revenue. For payers and competitors, this profile identifies the provider as a specialized, injection-centric retina operator whose Medicare performance is driven by a narrow set of high-impact codes.

Medicare: Complete Services Breakdown

The CPT/HCPCS codes generating the most Medicare revenue for this provider.

16 rows

CPT/HCPCS Code	Description	Claims	Avg Paid	Revenue
J0178	Injection, aflibercept, 1 mg	2,970	$690	$2M
67028	The provider injects a medication into the vitreous chamber of the eye as an isolated procedure or a separate procedure unrelated to any other procedure being performed on the eye.	1,780	$90	$160.3K
J2778	Injection, ranibizumab, 0.1 mg	650	$180	$116.6K
J2777	Injection, faricimab‑svoa, 0.1 mg	3,180	$30	$92.2K
92134	The provider performs computerized diagnostic imaging of the retina in the posterior segment (back part) of the eye, interprets the data, and provides a report. The service may be on one or both eyes.	2,160	$30	$62.5K
J7312	Injection, dexamethasone, intravitreal implant, 0.1 mg	290	$160	$45.3K
99214	The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the…	340	$80	$27.9K
J3590	Unclassified biologics	460	$40	$20.2K
99213	The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a low level of medical decision making, and/or the…	200	$60	$12.1K
92014	An ophthalmologist sees an established patient for a comprehensive level eye examination. Generally, a patient is considered to be "established" if the same physician, or any physician in the group…	120	$80	$9.5K

Showing 1–10 of 16

Medicare: Competitive Analysis & Benchmarks

How this provider's Medicare billing volume and revenue compare to other providers nationally and within its state, across 16 CPT/HCPCS codes.

View: State1 / 2

Claims Volume vs. Florida Distribution

Ahmed Alkaliby — 2 of 16 codes billed far more than typical (above p95)

p5–p95 (all providers)p25–p75MedianThis providerOutlier

Rank Distribution — Florida

Full comparison — all codes billed, vs. state median

16 rows

CPT/HCPCS Code	Rank	Provider Count	Median Claims	Avg Paid	Average Revenue
J0178	2	250	800	$690	$817.6K
J2777	48	170	12,810	$30	$549.2K
J2778	26	110	660	$180	$234.1K
67028	9	300	710	$90	$91.1K
J3590	10	20	30	$1,360	$50.3K
J7312	2	40	230	$160	$45.5K
92014	471	2,180	160	$80	$28.5K
99214	1,621	32,760	140	$90	$25K
99213	2,332	30,010	80	$60	$12K
92235	84	190	50	$100	$12K

Showing 1–10 of 16

Related Providers

Other providers that share a Tax Identification Number (TIN) with Ahmed Alkaliby, ranked by combined Medicare and Medicaid revenue.

Provider	State	Taxonomy	Medicare Revenue	Medicaid Revenue
Icare Health Solutions LLC	FL	Exclusive Provider Organization	$0	$80.3M
Associated Retinal Consultants, PC	MI	Ophthalmology Physician	$0	$21.1M
Cei Physicians Psc LLC	OH	Ophthalmology Physician	$0	$8.5M
Sandeep Randhawa	MI	Retina Specialist (Ophthalmology) Physician	$7M	$0
Elia Mavrofrides	FL	Ophthalmology Physician	$6.2M	$240
Scott Pendergast	OH	Retina Specialist (Ophthalmology) Physician	$6M	$0
Paul Raskauskas	FL	Retina Specialist (Ophthalmology) Physician	$5.2M	$0
Cei Physicians Psc LLC	OH	Ophthalmologic Surgery Clinic/Center	$4.1M	$1M
Keye Wong	FL	Retina Specialist (Ophthalmology) Physician	$4.9M	$0
Thomas Ward	FL	Retina Specialist (Ophthalmology) Physician	$4.7M	$0

Nearby Providers

Other providers in the same ZIP code as Ahmed Alkaliby, ranked by combined Medicare and Medicaid revenue.

Provider	State	Taxonomy	Medicare Revenue	Medicaid Revenue
Genesis Rehabilitation Hospital, Inc.	FL	Rehabilitation Hospital	$0	$40.8M
All Care Home Nursing Services, LLC	FL	Home Health Agency	$0	$39.7M
Family First Homecare, LLC	FL	Nursing Care Agency	$0	$26.9M
Memorial Healthcare Group Inc	FL	General Acute Care Hospital	$0	$19.4M
Daniel Memorial, Inc.	FL	Community/Behavioral Health Agency	$0	$16.6M
Ellis-moore Coroporation	FL	Pediatric Skilled Nursing Facility	$0	$9M
Total Renal Care Inc	FL	End-Stage Renal Disease (ESRD) Treatment Clinic/Center	$0	$7.8M
Social Care Services, LLC	FL	Mental Health Clinic/Center (Including Community Mental Health Center)	$0	$7.5M
Ameripro Ems Of Florida, LLC	FL	Land Ambulance	$4.4M	$2.2M
Ace Biomedical Labs, LLC	FL	Clinical Medical Laboratory	$5.7M	$222.4K

Ahmed Alkaliby — Billing Profile & Reimbursement Data

Sign up for Ahmed Alkaliby — Billing Profile & Reimbursement Data policy alerts

Ahmed Alkaliby — Billing Profile & Reimbursement Data

Sign up for Ahmed Alkaliby — Billing Profile & Reimbursement Data policy alerts

Key Findings

Medicare: Total Revenue Breakdown by CPT/HCPCS Code

Medicare: Complete Services Breakdown

Medicare: Competitive Analysis & Benchmarks

Related Providers

Nearby Providers

Frequently Asked Questions

References